• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

五味子甲素脂质体对 3T3-L1 脂肪细胞脂滴蓄积的抑制作用。

Deoxyschizandrin Loaded Liposomes on the Suppression Lipid Accumulation in 3T3-L1 Adipocytes.

机构信息

School of Integrated Traditional Chinese and Western Medicine, Binzhou Medical University, Yantai 264003, China.

School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.

出版信息

Molecules. 2018 Aug 27;23(9):2158. doi: 10.3390/molecules23092158.

DOI:10.3390/molecules23092158
PMID:30150602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6225205/
Abstract

Deoxyschizandrin (DS) is a bioactive benzocyclooctadiene lignan found in the fruit of . However, poor bioavailability and non-specificity of DS frequently caused low therapeutic efficacy. In the present study, DS-liposome (DS-lipo) was implemented to enhance the hepatic targeting and inhibition effects on adipocyte differentiation in 3T3-L1 cells. The formulations enabled encapsulation of as much as 24.14% DS. The DS-lipo prepared was about 73.08 nm, as measured by laser light scattering (LLS) morphology. In the visual field of a scanning electron microscope (SEM), the liposomes were spherical with similar size and uniform dispersion. Fluorescence live imaging study exhibited hepatic targeting of liposomes in vivo. Furthermore, High-Content Analysis (HCS) imaging microassay analyses revealed DS-lipo and DS reduced cytoplasmic lipid droplet in 3T3-L1 adipocytes, with the IC value of 8.68 μM and 31.08 μM, respectively. The lipid droplet accumulation inhibition rate of 10 μM DS-lipo was above 90%, which was even superior to the effect of 30 μM DS solution. The current findings suggest that DS-lipo was a therapeutic strategy for alleviating lipid-associated diseases and nonalcoholic fatty liver disease (NAFLD).

摘要

五味子甲素(DS)是一种生物活性苯丙素类木脂素,存在于五味子果实中。然而,DS 的生物利用度差且特异性低,常导致治疗效果低。在本研究中,采用 DS-脂质体(DS-lipo)提高 DS 的肝靶向性,并抑制 3T3-L1 细胞中的脂肪细胞分化。该制剂可将多达 24.14%的 DS 包封。通过激光光散射(LLS)形态学测量,制备的 DS-lipo 的直径约为 73.08nm。在扫描电子显微镜(SEM)的视野中,脂质体呈球形,具有相似的大小和均匀的分散性。荧光活体成像研究显示了脂质体在体内的肝靶向性。此外,高内涵分析(HCS)成像微分析表明,DS-lipo 和 DS 降低了 3T3-L1 脂肪细胞中的细胞质脂滴,其 IC 值分别为 8.68 μM 和 31.08 μM。10 μM DS-lipo 的脂滴积累抑制率超过 90%,甚至优于 30 μM DS 溶液的效果。目前的研究结果表明,DS-lipo 是一种治疗与脂质相关疾病和非酒精性脂肪肝(NAFLD)的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f787/6225205/34a082440018/molecules-23-02158-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f787/6225205/5e9e7b76811f/molecules-23-02158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f787/6225205/093ded9fd630/molecules-23-02158-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f787/6225205/c9fcff63436e/molecules-23-02158-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f787/6225205/16074e1addb4/molecules-23-02158-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f787/6225205/9d1870564bf0/molecules-23-02158-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f787/6225205/34a082440018/molecules-23-02158-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f787/6225205/5e9e7b76811f/molecules-23-02158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f787/6225205/093ded9fd630/molecules-23-02158-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f787/6225205/c9fcff63436e/molecules-23-02158-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f787/6225205/16074e1addb4/molecules-23-02158-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f787/6225205/9d1870564bf0/molecules-23-02158-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f787/6225205/34a082440018/molecules-23-02158-g006.jpg

相似文献

1
Deoxyschizandrin Loaded Liposomes on the Suppression Lipid Accumulation in 3T3-L1 Adipocytes.五味子甲素脂质体对 3T3-L1 脂肪细胞脂滴蓄积的抑制作用。
Molecules. 2018 Aug 27;23(9):2158. doi: 10.3390/molecules23092158.
2
Gomisin N from Ameliorates Lipid Accumulation and Induces a Brown Fat-Like Phenotype through AMP-Activated Protein Kinase in 3T3-L1 Adipocytes.五味子甲素通过激活 3T3-L1 脂肪细胞中的 AMP 激活蛋白激酶改善脂质积累并诱导产热棕色脂肪样表型。
Int J Mol Sci. 2020 Mar 20;21(6):2153. doi: 10.3390/ijms21062153.
3
Pharmacokinetics and liver uptake of three Schisandra lignans in rats after oral administration of liposome encapsulating β-cyclodextrin inclusion compound of Schisandra extract.脂质体包封的五味子提取物β-环糊精包合物灌胃后大鼠体内三种五味子木脂素的药代动力学和肝摄取。
J Liposome Res. 2019 Jun;29(2):121-132. doi: 10.1080/08982104.2018.1430830. Epub 2019 Mar 1.
4
Schisandrin B regulates lipid metabolism in subcutaneous adipocytes.五味子乙素调节皮下脂肪细胞中的脂质代谢。
Sci Rep. 2017 Aug 31;7(1):10266. doi: 10.1038/s41598-017-10385-z.
5
Suppression of adipocyte differentiation and lipid accumulation by stearidonic acid (SDA) in 3T3-L1 cells.硬脂烯酸(SDA)抑制 3T3-L1 细胞中的脂肪细胞分化和脂质积累。
Lipids Health Dis. 2017 Sep 25;16(1):181. doi: 10.1186/s12944-017-0574-7.
6
Comparative pharmacokinetics and tissue distribution of schisandrin, deoxyschisandrin and schisandrin B in rats after combining acupuncture and herb medicine (schisandra chinensis).针刺联合中药(五味子)后大鼠体内五味子醇甲、脱氧五味子醇甲和五味子乙素的比较药代动力学及组织分布
Biomed Chromatogr. 2014 Aug;28(8):1075-83. doi: 10.1002/bmc.3122. Epub 2014 Jan 29.
7
[Pharmacokinetics and tissue distribution of Schisandra chinensis extract in mice].
Zhong Yao Cai. 2011 Dec;34(12):1912-5.
8
Schisandra lignans-loaded enteric nanoparticles: preparation, characterization, and in vitro-in vivo evaluation.五味子木脂素载肠纳米粒的制备、表征及体内外评价。
J Drug Target. 2013 Feb;21(2):180-7. doi: 10.3109/1061186X.2012.737000.
9
Cycloastragenol, a triterpene aglycone derived from Radix astragali, suppresses the accumulation of cytoplasmic lipid droplet in 3T3-L1 adipocytes.环黄芪醇是一种从黄芪中提取的三萜苷元,可抑制 3T3-L1 脂肪细胞中细胞质脂滴的积累。
Biochem Biophys Res Commun. 2014 Jul 18;450(1):306-11. doi: 10.1016/j.bbrc.2014.05.117. Epub 2014 Jun 2.
10
Temperature induced modulation of lipid oxidation and lipid accumulation in palmitate-mediated 3T3-L1 adipocytes and 3T3-L1 adipocytes.温度诱导对棕榈酸酯介导的3T3-L1脂肪细胞及3T3-L1脂肪细胞中脂质氧化和脂质积累的调节作用
J Therm Biol. 2016 May;58:1-7. doi: 10.1016/j.jtherbio.2016.03.008. Epub 2016 Mar 19.

引用本文的文献

1
A comprehensive review of Schisandra chinensis lignans: pharmacokinetics, pharmacological mechanisms, and future prospects in disease prevention and treatment.五味子木脂素的综合综述:药代动力学、药理机制及疾病防治的未来前景
Chin Med. 2025 Apr 9;20(1):47. doi: 10.1186/s13020-025-01096-z.
2
Nano-drug delivery systems (NDDS) in metabolic dysfunction-associated steatotic liver disease (MASLD): current status, prospects and challenges.代谢功能障碍相关脂肪性肝病(MASLD)中的纳米药物递送系统(NDDS):现状、前景与挑战
Front Pharmacol. 2024 Aug 6;15:1419384. doi: 10.3389/fphar.2024.1419384. eCollection 2024.
3
Potential of (Turcz.) Baill. in Human Health and Nutrition: A Review of Current Knowledge and Therapeutic Perspectives.

本文引用的文献

1
Agrimol B suppresses adipogenesis through modulation of SIRT1-PPAR gamma signal pathway.仙鹤草酚B通过调节SIRT1-PPARγ信号通路抑制脂肪生成。
Biochem Biophys Res Commun. 2016 Aug 26;477(3):454-60. doi: 10.1016/j.bbrc.2016.06.078. Epub 2016 Jun 16.
2
Anti-Cancer Efficacy of Paclitaxel Loaded in pH Triggered Liposomes.pH 触发脂质体负载紫杉醇的抗癌疗效
J Biomed Nanotechnol. 2016 Jan;12(1):79-90. doi: 10.1166/jbn.2016.2123.
3
Schisandra chinensis extract ameliorates nonalcoholic fatty liver via inhibition of endoplasmic reticulum stress.
土木香(Turcz.)Baill. 在人类健康和营养中的潜力:对现有知识和治疗观点的综述。
Nutrients. 2019 Feb 4;11(2):333. doi: 10.3390/nu11020333.
五味子提取物通过抑制内质网应激改善非酒精性脂肪肝。
J Ethnopharmacol. 2016 Jun 5;185:96-104. doi: 10.1016/j.jep.2016.03.021. Epub 2016 Mar 10.
4
A comprehensive production method of self-cryoprotected nano-liposome powders.一种自保护纳米脂质体粉末的综合生产方法。
Int J Pharm. 2015;486(1-2):153-8. doi: 10.1016/j.ijpharm.2015.03.038. Epub 2015 Mar 18.
5
Liposomes as nanomedical devices.作为纳米医疗设备的脂质体。
Int J Nanomedicine. 2015 Feb 2;10:975-99. doi: 10.2147/IJN.S68861. eCollection 2015.
6
Size dependent variations of phospholipid based vesicular drug carriers in systemic drug activity.基于磷脂的囊泡药物载体在全身药物活性方面的尺寸依赖性变化
Curr Pharm Biotechnol. 2015;16(4):380-91. doi: 10.2174/1389201016666150206105149.
7
Nanoparticle-triggered release from lipid membrane vesicles.纳米颗粒触发脂质膜囊泡释放。
N Biotechnol. 2015 Dec 25;32(6):665-72. doi: 10.1016/j.nbt.2014.12.002. Epub 2014 Dec 19.
8
Obesity, fatty liver disease and intestinal microbiota.肥胖、脂肪肝疾病与肠道微生物群
World J Gastroenterol. 2014 Nov 28;20(44):16452-63. doi: 10.3748/wjg.v20.i44.16452.
9
The protective mechanism of schisandrin A in d-galactosamine-induced acute liver injury through activation of autophagy.五味子醇甲通过激活自噬在D-氨基半乳糖诱导的急性肝损伤中的保护机制
Pharm Biol. 2014 Oct;52(10):1302-7. doi: 10.3109/13880209.2014.890232. Epub 2014 Jul 3.
10
Near-infrared fluorescence imaging using organic dye nanoparticles.近红外荧光成像技术使用有机染料纳米粒子。
Biomaterials. 2014 Mar;35(10):3356-64. doi: 10.1016/j.biomaterials.2014.01.004. Epub 2014 Jan 21.